6-Azido-6-deoxy-beta-cyclodextrin>95.0%(HPLC)1g

(R)-1-(5-methylfuran-2-yl)ethanamine hydrochloride, 97+%, 100mg

3-Amino-1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid, 98%, 50mg

p-Xylène, min.99%, pour la synthèse, 500 ml, emballage en verre

2-Fluoro-4-iodo-1-nitrobenzene, 95.0%, 10g

2-Diphenylphosphino-2'-(N,N-dimethylamino)biphenyl, 95.0%, 5g

Ethyl (2R,3R)-3-amino-2-hydroxy-3-phenylpropanoate, 98%, 10g

2-Amino-5-iodo-3-methylbenzoic acid, 95.0%, 1g

2-(4-Chlorophenyl)-2-cyanoacetaldehyde, 95.0%, 250mg

N-(Quinolin-6-yl)acetamide, 95.0%, 1g

(4-Methyl-6-(methylsulfonyl)pyridin-3-yl)boronic acid pinacol ester, 95+%, 1g

3-(4-Fluoro-phenylsulfanylmethyl)-piperidine-1-carboxylic acid tert-butyl ester, 95.0%, 250mg

4-Octyl-3-thiosemicarbazide, 97%, 5g